Header
PUBLICATIONS AND REPORTS
 
Search Website
GO
Publications
 
CONTINUING OR CEASING BEVACIZUMAB BEYOND PROGRESSION IN RECURRENT GLIOBLASTOMA: AN EXPLORATORY RANDOMIZED PHASE II TRIAL
Elizabeth J Hovey, Kathryn M Field, Mark A Rosenthal, Elizabeth H Barnes, Lawrence Cher, Anna K Nowak, Helen Wheeler, Kate Sawkins, Ann Livingstone, Pramit Phal, Christine Goh, John Simes, on behalf of CABARET/COGNO investigators. Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial. Neuro-Oncology Practice. Published online 25 May 2017. Abstract available on https://doi.org/10.1093/nop/npw025
  
HEALTH-RELATED QUALITY OF LIFE OUTCOMES FROM CABARET: A RANDOMIZED PHASE 2 TRIAL OF CARBOPLATIN AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA

Kathryn M. Field, Madeleine T. King, John Simes, David Espinoza, Elizabeth H. Barnes, Kate Sawkins, Mark A. Rosenthal, Lawrence Cher, Elizabeth Hovey, Helen Wheeler, Anna K. Nowak. Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma. Journal of Neuro-Oncology. Published online 22 May 2017. Article available on http://dx.doi.org/10.1007/s11060-017-2479-8
 
IMPACT OF COGNITIVE FUNCTION ON COMMUNICATION IN PATIENTS WITH PRIMARY OR SECONDARY BRAIN TUMOURS (COGNO ENDORSED STUDY)
Diana N. Naehrig, Eng-Siew Koh, Monica Vogiatzis, Waka Yanagisawa, Carol Kwong, Heather L. Shepherd, Chris Milross, Haryana M. Dhillon. Impact of cognitive function on communication in patients with primary or secondary brain tumours. Journal of Neuro-Oncology. Published online 26 October 2015. Article available on http://link.springer.com/article/10.1007%2Fs11060-015-1964-1

VALIDATING SELF-REPORT AND PROXY REPORTS OF THE DEXAMETHASONE SYMPTOM QUESTIONNAIRE -CHRONIC FOR THE EVALUATION OF LONGER-TERM CORTICOSTEROID TOXICITY
Meera Agar, Eng-Siew Koh, Emma Gibbs, Elizabeth H. Barnes, Elizabeth Hovey, Ann Livingstone, Kate Sawkins, Richard Chye, Melanie R. Lovell, Katherine Clark, Janette Vardy, Madeleine King, On behalf of the Cooperative Trials Group for Neuro-Oncology (COGNO). Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity. Supportive Care in Cancer. Published online 21 August 2015. Article available on http://link.springer.com/article/10.1007/s00520-015-2897-0

RANDOMIZED PHASE 2 STUDY OF CARBOPLATIN AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA
Kathryn M. Field, John Simes, Anna K. Nowak, Lawrence Cher, Helen Wheeler, Elizabeth J. Hovey, Christopher S.B. Brown, Elizabeth H. Barnes, Kate Sawkins, Ann Livingstone, Ron Freilich, Pramit M. Phal, Greg Fitt, CABARET/COGNO investigators and Mark A. Rosenthal. Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma. Neuro-Oncology. Published online 30 June 2015. Article available on https://doi.org/10.1093/neuonc/nov104

PATTERNS OF CARE IN ADULT MEDULLOBLASTOMA
Cosman R, Brown CSB, DeBraganca KC, Khasraw M, for the Cooperative Trials Group for Neuro-Oncology (COGNO). Patterns of care in adult medulloblastoma: results of an international online survey. Journal of Neuro-Oncology. 16 July 2014 Epub ahead of print. Article available on http://link.springer.com/article/10.1007/s11060-014-1525-z

CULTURALLY AND LINGUISTICALLY DIVERSE PATIENT PARTICIPATION IN GLIOMA RESEARCH

Lwin Z, Broom A, Cosman R, Livingstone A, Sawkins K, Good P, Kirby E, Koh ES and Hovey E on behalf of the COGNO CALD working group. Culturally and linguistically diverse patient participation in glioma research. Neuro-Oncology Practice. 25 June 2014 Epub ahead of print. Article available on http://dx.doi.org/10.1093/nop/npu009

NEURO-ONCOLOGY PRACTICES IN AUSTRALIA
Chen JY, Hovey E, Rosenthal M, Livingstone A, Simes J, for the Cooperative Trials Group for Neuro-Oncology (COGNO). Neuro-Oncology practices in Australia: A Cooperative Group for Neuro-Oncology patterns of care study. Asia-pacific Journal of Clinical Oncology. 29 May 2013 Epub ahead of print. Article available on http://dx.doi.org/10.1111/ajco.12079

GLIOBLASTOMA MULTIFORME
Ananda S, Nowak AK, Cher L, Dowling A, Brown C, Simes J, Rosenthal MA, for the Cooperative Trials Group for Neuro-Oncology (COGNO). Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy. Journal of Clinical Neuroscience. Published online 2 August 2011. Article available on https://linkinghub.elsevier.com/retrieve/pii/S0967-5868(11)00222-0
 

Reports
 
2010 COGNO PATTERNS OF CARE STUDY IN NEURO-ONCOLOGY IN AUSTRALIA
Chen JY, Hovey E, Rosenthal M, Livingstone A, Simes J. Report available here: 2010 COGNO Patterns of Care Study in Neuro-oncology in Australia.